TENS Treatment for Fatigue in Multiple Sclerosis

Reducing Fatigue in People With Multiple Sclerosis by Treatment With TENS

Recruiting N/A Interventional Study
Multiple Sclerosis
No Placebo Group Every participant receives an active treatment — no one gets a placebo.
Ready to participate?

Review the details below, then apply to join this clinical trial.

At a Glance
Age
18 – 65
Sex
Any
Study type
Interventional
Purpose
Treatment
Participants needed
60 (estimated)
Sponsor
University of Colorado, Boulder · Other
Who this trial is looking for

This trial is looking for people with multiple sclerosis who are experiencing fatigue. Participants will receive treatment using a method called TENS to help reduce their fatigue levels.

Are You a Good Fit for This Trial?
Must be taking AmpyraProvigil
Must not be taking AntidepressantsAnticholinergicsStimulantsSedativesCannabisIllicit drugs
Rules you out Diabetes mellitusHypertensionSeizure disorders

You may be able to join if

  • I am between 18 and 65 years old.
  • I can read, understand, and speak English.
  • I have been diagnosed with relapsing-remitting multiple sclerosis.
  • I have difficulty walking.
  • I have been stable on my current medications.
  • I have not had a relapse or received systemic steroids in the last 30 days.
  • I can get to the Boulder campus.

You may not be able to join if

  • I have uncorrected vision or hearing problems.
  • I have issues sensing temperature, pressure, or pain.
  • I have arm or leg problems that affect my ability to hold weight.
  • I have had bothersome surgery on my arms or legs.
  • I have metal implants.
  • I have a medical condition that makes exercise risky for me.
  • I have a history of head injury or stroke.
  • I drink 2 or more alcoholic drinks a day.

Summarized in plain language from this trial's official eligibility criteria. The full criteria are further down this page — only the research team can confirm whether you qualify.

Think this trial could be right for you?

Answer three quick questions written from this study's own rules to see if you may qualify. No account needed to find out.

Check Your Eligibility
About This Trial

The objective of the randomized, sham-controlled trial will be to evaluate the effectiveness of treatment with transcutaneous electrical nerve stimulation (TENS) at reducing the level of fatigue experienced by people with MS.

Trial Locations
Loading…

Loading trial locations…

Eligibility Criteria
Inclusion Criteria: * Men and women18-65 yrs * Able to read, understand, and speak English to ensure safe participation in the project * Clinical diagnosis of relapsing-remitting MS * Self-reported difficulty with walking * On stable doses of Ampyra, provigil, or other symptomatic-treating medicati…
Contacts

Roger Enoka, PhD

3034927232

enoka@colorado.edu

CONTACT